SCHEMBL30104231

SCHEMBL30104231

CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(F)(C(F)(F)F)C(F)(F)F)ccc3F)cc2)ccn1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 10/20 0.69
EPHX2 P34913 4/20 0.67
KDR P35968 7/20 0.64
ABL1 P00519 4/20 0.64
RET P07949 4/20 0.64
MAPK14 Q16539 4/20 0.64
EPHA2 P29317 3/20 0.64
MAP3K20 Q9NYL2 3/20 0.64
SRC P12931 3/20 0.64
PLK4 O00444 2/20 0.64
AURKA O14965 2/20 0.64
MAPK13 O15264 2/20 0.64
MAP4K4 O95819 2/20 0.64
LCK P06239 2/20 0.64
FYN P06241 2/20 0.64
LYN P07948 2/20 0.64
RPS6KB1 P23443 2/20 0.64
AXL P30530 2/20 0.64
FRK P42685 2/20 0.64
MAPK9 P45984 2/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19878582 1.00 RAF1 (0.69) RAF1EPHX2KDRABL1RET
SCHEMBL21124513 0.96 RAF1 (0.66) RAF1EPHX2KDRABL1RET
SCHEMBL21084300 0.93 RAF1 (0.69) RAF1EPHX2KDRABL1RET
SCHEMBL1660411 0.93 RAF1 (0.80) RAF1EPHX2KDRABL1RET
SCHEMBL21125009 0.92 BRAF (0.63) RAF1EPHX2KDRABL1RET
SCHEMBL21125213 0.91 RAF1 (0.67) RAF1EPHX2KDRABL1RET
SCHEMBL21124504 0.91 RAF1 (0.69) RAF1EPHX2KDRABL1RET
SCHEMBL19888748 0.91 RAF1 (0.77) RAF1EPHX2KDRABL1RET
SCHEMBL21125214 0.90 RAF1 (0.66) RAF1EPHX2KDRABL1RET
SCHEMBL29649810 0.90 RAF1 (0.71) RAF1EPHX2KDRABL1RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250281607-A1 MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER TORAY INDUSTRIES, INC. (JP) 2025-09-11 US disclosed
EP-3500257-B1 KINASE INHIBITOR COMPOUNDS, COMPOSITIONS, AND METHODS OF TREATING CANCER ICAHN SCHOOL MED MOUNT SINAI (US) 2025-07-02 EP disclosed
WO-2024178274-A2 METHODS OF DEGRADING RAF(RAF) PROTEIN IN CELLS USING MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1/2 (MEK1/2) PROTEIN DEGRADERS INSTITUTE FOR CANCER RESEARCH D/B/A THE RESEARCH INSTITUTE OF FOX CHASE CANCER CENTER (US) 2024-08-29 WO disclosed
EP-4378478-A1 MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER Toray Industries, Inc. (JP) 2024-06-05 EP disclosed
CN-117677398-A Medicine for treating and/or preventing cancer 东丽株式会社 2024-03-08 CN disclosed
WO-2023008462-A1 MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER 東レ株式会社 2023-02-02 WO disclosed